The Predictive Value of the aCL and Anti-β2GPI at the Time of Acute Deep Vein Thrombosis—A Two-Year Prospective Study (original) (raw)
Factors Associated with the Deep Vein Thrombosis in Patients with Antiphospholipid Syndrome
Anda Baicus
Romanian Journal of Rheumatology
View PDFchevron_right
High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: ‘PROS’ and ‘CONS’
Vittorio Pengo
Autoimmunity Reviews, 2012
View PDFchevron_right
Anti–β2-Glycoprotein I and Antiphosphatidylserine Antibodies Are Predictors of Arterial Thrombosis In Patients With Antiphospholipid Syndrome
Daniel Lopez
American journal of …, 2004
View PDFchevron_right
The Adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) and the Risk of Recurrent Thrombosis: Results from the APS ACTION cohort
Maria Efthymiou
Seminars in Arthritis and Rheumatism
View PDFchevron_right
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
Vittorio Pengo, P. Gresele
Journal of Thrombosis and Haemostasis, 2010
View PDFchevron_right
Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients With Antiphospholipid Syndrome
Abraham Majluf-cruz
Clinical and Applied Thrombosis/Hemostasis, 2017
View PDFchevron_right
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Kenji Oku
Arthritis & Rheumatism, 2012
View PDFchevron_right
Longterm anticoagulation is preferable for patients with antiphospholipid antibody syndrome. result of a decision analysis
Jeffrey Ginsberg
The Journal of rheumatology, 2002
View PDFchevron_right
Persistency of low levels of anticardiolipin and anti-Beta2 Glycoprotein1 in thrombosis
Marta Amaral
European Journal of Internal Medicine, 2010
View PDFchevron_right
Anti-b2-Glycoprotein I and Antiphosphatidylserine Antibodies Are Predictors of Arterial Thrombosis in Patients With Antiphospholipid Syndrome
daniel lopez
American Journal of Clinical Pathology, 2004
View PDFchevron_right
Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study
Zakera Shums
Rheumatology, 2015
View PDFchevron_right
Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies
Jeannine Kassis
Thrombosis and haemostasis, 2003
View PDFchevron_right
The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome
Sabrina da Silva Saraiva
American journal of hematology, 2017
View PDFchevron_right
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis
Jesus Aibar
Seminars in Thrombosis and Hemostasis
View PDFchevron_right
Direct Oral Anticoagulants in Patients with Antiphospholipid Syndrome: Results from a Retrospective Study in a Real-life Patient Cohort
Elżbieta Broniatowska
Science meets clinical practice, 2019
View PDFchevron_right
Usefulness of a Diluted Prothrombin Time for Accurately Diagnosing Antiphospholipid Syndrome
Kaname Nakatani
Vascular Disease Prevention, 2009
View PDFchevron_right
Risk factors associated with thrombosis in patients with antiphospholipid antibodies
Karen Hansen
The Journal of rheumatology, 2001
View PDFchevron_right
Misdiagnosis of high thrombotic risk triple-positive antiphospholipid antibodies
Stephany Cares Huber
Thrombosis research, 2020
View PDFchevron_right
Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome
luis lopez
American journal of clinical pathology, 2004
View PDFchevron_right
Predictors of mortality in primary antiphospholipid syndrome
Vincenzo Marottoli
Thrombosis and Haemostasis, 2016
View PDFchevron_right
Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence
Gabriela Medina
Autoimmunity Reviews, 2017
View PDFchevron_right
Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy
Sam Schulman
The American Journal of Medicine, 1998
View PDFchevron_right
Patterns of Recurrent Thrombosis in Primary Antiphospholipid Syndrome—Multicenter, Real-Life Long-Term Follow-Up
soad haj yahia
Frontiers in Immunology
View PDFchevron_right
Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties
Zsuzsa Bagoly
Kardiologia Polska, 2019
View PDFchevron_right
Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification
Vittorio Pengo
Journal of Thrombosis and Haemostasis, 2008
View PDFchevron_right
Antiphospholipid syndrome; its implication in cardiovascular diseases: a review
Efstratios Apostolakis, Stavros Siminelakis
Journal of Cardiothoracic Surgery, 2010
View PDFchevron_right